INTRODUCTION
Continuous cultures of lymphoblastic cells miiay be derived from patielnts with leukemia and lymviplhomiia (1) , infectious nmononucleosis (2), and from healthy volunteers (3) . Allogeneic cultured lymphoblasts stimulate lymphocvte transformation in mixed culture more than do allogeneic leukocytes (4) . Several investigators have found that cuiltured lvnmphoblasts fronm healthsx subjects solubilizer was purchased from the Nuclear Chicago Co., Arlington Heights, Ill.
Continuous human. ly mtphoblast cutltures. Continuous cultures of human lymphoblasts were established using methods of Broder, Glade, and Hirschhorn (10). 30-50 ml of heparinized blood (10 U/ml) was sedimented in the syringe at 37°C for 2-3 hr. TI.e white cell-rich plasma was expressed and leukocytes collected by centrifugatioii (150 g for 3(0 miii). The leukocytes w,ere susl)ended at a conicentrationi of 1-3 X 106 cells/ml in culture medium and 20% fetal bovine serum to which L-gllitamiine 2 gumoles/ml were added. 10 ml of this preparation was place(l into 25 ml culture flasks with 0.25 gg of phytohemagglutinin M R-69. The flasks were tightly capped and inicubhated horizontally at 370 C. Twice weekly 5 ml of the culture me(liuim was removed and fresh medium (without phytolemagglutinin') added. After 30-90 days cell lines were established as maniifested by the media becoming acidic and by the presence of clusters of lymphoblasts. 5 ml of media and lymphoblasts from established cultures could then be transferred to 125-ml flasks.
The lymphoblast concenitration ranged from 1 to 5 X 10'/ ml. Lymphoblasts were collected by centrifugation (150 g for 10 min) and normally resuspended at a concentrationi of 2 X 106/ml in culture medium. Cell viability was measured by the exclusion of trypan blue as (lescribe(l by Boyse, Old, and Chouroulinkov (11) .
Thlwnidine incorporation by huminan blood lytmphocytes.
Stimulationi of thymidine incorporation into lymphocyte D)NA by phytohemagglutiniin or by autologous or allogeneic lymphoid cells was measured. Peripheral blood leukocytes were obtained as described above. The concenitration of lymphocytes in the white cell-rich plasma was adjusted to 2 X 106/ml. Lymphocyte transformation stimulated by phytohemagglutinin was measured by mixing 0.4 ml of the leukocyte preparation with 1.6 ml culture medium containing 0.025 ml of the stock phytohemagglutinin-M (5 ml of sterile water added to vial) solution in 13 x 100 mm sterile glass tubes covered with plastic closures. Cultures were incubated 66 hr at 37°C in a 5% C02/95%o air atmosphere. 2i g.Ci of thymidine-3H in 0.025 ml was added and the incubation continued for 6 hr. The culture tubes were then filled with 0.15 M sodium chloride and the cells were collected by centrifugation. The hr. The increase in the rate of thymidine incorporation during the incubation of lymphocytes with autologous lymphoblasts parallels that seen with phytohemagglutinin and differs from that seen in a one-way mixed leukocyte reaction. Whether this difference in stimulating capacity of allogeneic leukocytes and autologous lymphoblasts is due to the activation of different populations of lymphocytes or to stimullation of a different rate of cell division is not clear.
Lymnphocyte stiunulation by allogcteic leukocytes and cultured lymphoblasts. Lymphocyte transformation stimulated by optimal concentrations (9) of cultured lymphoblasts and of allogeneic leukocytes was coxnpared. The results of four representative experiments are shown in Table III . The stimulation of lymphocyte transformation is measured relative to the "background" amount of thymidine incorporated by lymphocytes xnixed with irradiated autologous leukocytes. Allogeneic leukocytes stimulate a 10-93-fold increase in thymidine incorporated, into lymphocyte DNA. Allogeneic lymphoblasts stimulated a 40-270-fold increase in thymidine incorporation. Allogeneic cultured lymphoblasts always stimulated more thymidine incorporation than did allogeneic leukocytes. No relationship was observed between the degree of stimulation of thymidine incorporation bv allogeneic leukocytes and by cultured lymphoblasts from the same donor. Thus, the cell donor whose leukocytes most stimulated lymphocyte transformation was not necessarily the donor (14) . Concanavalin A at concentrations between 100 and 500 /Ag/ml was found to agglutinate cultured lymphoblasts (Table VIII) . Significant agglutination was found with each of three cultured lymphoblast lines studied. Purified blood lymphocytes (15) from the lymphoblast donors showed only trace agglutination at the highest concentration of concanavalin A tested.
The relationship between the concanavalin A binding sites on the cultured lymphoblast and their stimulation of autologous lymphocyte transformation was studied. As concanavalin A is a potent xnitogen it could not itself be used for such studies. Trypsin-treated concanavalin A lhas been shown by Burger and Noonan to retain its capacity to bind but not to agglutinate transformed cells (16) . We found that trypsin-treated concanavalin A retained little mitogenic activity (Table IX) and did not depress the viability of cultured lvmphoblasts as measured by a trypan blue assay. A mixture of concanavalin A and trypsin-treated concanavalin A stimulated lymphocyte transformation normally. This proved the absence of an inhibitor of lymphocyte transformation in the trypsin-treated concanavalin preparation. The effect of trypsin-treated concanavalin A on the stimulatory capacity of cultured lymphoblasts was investigated. Cultured lymphoblasts incubated for 30 min with trypsintreated concanavalin A stimulated significantly less lymphocyte transformatioin than did untreated cultured lym- time required for maximal lymphocyte transformation, (b) the necessity for intact cultured lymphoblasts in physical contact with the responding cell population (4, 17) , and (c) the lack of participation of widely diffusible mlitogenic factors. Amos and Bach (18) have shown that the miiixed leukocyte reaction is dependent upon differences in determinants identical or closely linked to the histocompatibility antigens. In contrast, lymphocyte transformation stimulated by cultured lymphoblasts is not related to differences in the HL-A determinants on the lymphoblast as evidenced by the observations that: (a) lymphoblasts stimulate autologous lymphocyte transformation, (b) the response of lymphocytes to allogeneic cultured lymphoblasts does not parallel their response to allogeneic leukocytes from the cell line donior. and (c) the kinetics of thymidine incorporationi stimulated by autologous lymnphoblasts resembles the response to plhytohemagglutiniin more thain it does a miiixed leukocyte reaction. There is evidence that HL-A antigenic density is greater on cultured lymphoblasts than on peripheral lymphocytes (19) . This observation may contribute to the increased response of lymphocytes to allogeineic cultured lymphoblasts as compared with allogeneic leukocytes from the cell line donor and may underlie the reported appearance of "new" HL-A determinants on cultured lymphoblasts (8.
20).
The results reported lhere suggest that presence of a lymphloblast-associated antigeni. The existence of determiinants on lymphoblasts not found on lymphocytes has been suggested by cross-absorption studies usinlg antiserumii raised to lymiiphoblasts and to blood lvmphocytes (21) . Recent studies by Mann, Rogentine, Halterman, and Leventhal (22) showed that a non-HL-A determinant found on cultured lymphoblasts is present on leukocytes from leukemic patients and some of their relatives but not on the leukocytes of unrelated normal individuals. This is relevant because leukemic cells have been reported to stimulate transformation of autologous lymphocytes (23) and of lymphocytes from HL-A identical siblings (24) . These findings suggested the existence of a leukemia-associated antigeni. It is possible that the lyniphoblast-associated antigen mar' be related to a leuikemiaatssociated anitigen.
Tumor cells, cells transformed by viral and chemical carcinogens (14) , and embryonic cells (25) (27) . The best studied example of this phenomenon is the demonstration by Gold and Freedman (28) of an antigenic determinant on colonic carcinoma cells which is also present on embryonic endodermal tissue. The second hypothesis proposes that cells with new antigenic determinants are infected with virus and that the new determinant results from the expression of viral genetic material. Many surface determinants results from the expression of viral genetic material (29) .
At present, there is no evidence that new antigenic determinants found on the cultured lymphoblast are present on primitive hematopoietic cells. We have, however, preliminary evidence that mitogen-induced lymphoblasts also stimulate autologous lymphocyte transformation and may contain similar antigenic determinants (30) .
Cultured lymphoblasts are frequently infected with EB virus. In fact, it has been suggested that in vivo (31) or in vitro (32) infection with the EB virus is a prerequisite for the establishment of lymphoblasts in continuous culture. EB virus or EB antigen can be demonstrated -in the majority of cultured lymphoblast lines (31) . Cultured lymphoblast lines that possess neither EB virus nor EB antigen can be shown to contain the EB viral genome by DNA-RNA hybridization techniques (33) and recently EB virus has been induced from presumed "virus-free" lines after incubation with bromodeoxyuridine (34, 35) . At this time it is not possible to rule out a relationship between EB virus infection and the development of the stimulatory determinants on cultured lymphoblasts. Although cultured lymphoblasts that stimulate autologous lymphocyte transformation do not always have demonstrable EB viral antigens (9) , it is possible that EB viral antigens contribute to the stimulation of lymphocyte transformation. Whether EB viral antigens are destroyed following exposture to trypsin is not known.
Finally, the biological significance of the in vitro response of lymphocytes to autologous cells should be considered. The transformation of lymphocytes in culture may reflect the in vitro phenomenon of immune surveillance. The disappearance of atypical lymphocytes from the circulation during recovery from infectious mononucleosis follows and may result from the sensitization of the host to determinants on the atypical lymphocyte. This may be the biologic consequence of the in vitro phenomenon described in these studies. In general termiis the ability of lymphocytes from normal individuals to react with blast transformation to cultured autologouis cells may reflect a primary mechanism to colntrol neoplastic transformation.
